Sarah L. Pogue,David S. Wilson,Anthony Gerard Doyle,Collette Jane Behrens
申请号：
US14701628
公开号：
US20150313965A1
申请日:
2015.05.01
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Methods for cancer treatment include administering to a cancer patient an anti-CD38 antibody-attenuated human IFN alpha-2b construct and lenalidomide or pomalidomide. Tumors that may be treated according to these methods include tumors which comprise CD-38 expressing tumor cells, including B-cell lymphoma, multiple myeloma, non-Hodgkin's lymphoma, chronic myelogenous leukemia, chronic lymphocytic leukemia, and acute lymphocytic leukemia.
